TR200003521T2 - Re-combined human interferon beta-1a (IFN-beta-1a) formulation. - Google Patents

Re-combined human interferon beta-1a (IFN-beta-1a) formulation.

Info

Publication number
TR200003521T2
TR200003521T2 TR2000/03521T TR200003521T TR200003521T2 TR 200003521 T2 TR200003521 T2 TR 200003521T2 TR 2000/03521 T TR2000/03521 T TR 2000/03521T TR 200003521 T TR200003521 T TR 200003521T TR 200003521 T2 TR200003521 T2 TR 200003521T2
Authority
TR
Turkey
Prior art keywords
beta
ifn
formulation
human interferon
combined human
Prior art date
Application number
TR2000/03521T
Other languages
Turkish (tr)
Inventor
Alam John
Rogge Mark
Goelz Susan
Original Assignee
Biogen, Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen, Inc filed Critical Biogen, Inc
Publication of TR200003521T2 publication Critical patent/TR200003521T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Abstract

Bulus, yaklasik pH 7.2 degerinde tampon, yeniden-kombine-edilen interferon-beta ve 15 mg/ml insan serum albumini içeren sivi bilesimleri ve sözü geçen bilesimlerin parenteral kullanimi için kullanma takimlarini saglamaktadir.The invention provides liquid compositions containing buffer at about pH 7.2, recombinant interferon-beta and 15 mg / ml human serum albumin, and use kits for parenteral use of said compounds.

TR2000/03521T 1998-05-29 1998-05-29 Re-combined human interferon beta-1a (IFN-beta-1a) formulation. TR200003521T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/007242 WO1999062542A1 (en) 1998-05-29 1998-05-29 Recombinant human interferon beta-1a (ifn-beta-1a) formulation

Publications (1)

Publication Number Publication Date
TR200003521T2 true TR200003521T2 (en) 2001-07-23

Family

ID=22266817

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03521T TR200003521T2 (en) 1998-05-29 1998-05-29 Re-combined human interferon beta-1a (IFN-beta-1a) formulation.

Country Status (16)

Country Link
EP (1) EP1082132A1 (en)
JP (1) JP2002516874A (en)
KR (1) KR20010052454A (en)
CN (1) CN1299285A (en)
AU (1) AU8822598A (en)
BR (1) BR9815966A (en)
CA (1) CA2333063A1 (en)
EA (1) EA200001252A1 (en)
EE (1) EE200000694A (en)
HU (1) HUP0102241A2 (en)
IL (1) IL139933A0 (en)
IS (1) IS5732A (en)
NO (1) NO20006022L (en)
SK (1) SK17762000A3 (en)
TR (1) TR200003521T2 (en)
WO (1) WO1999062542A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020025304A1 (en) * 2000-06-16 2002-02-28 Croze Edward M. Novel interferon for the treatment of multiple sclerosis
DE60130145T2 (en) * 2000-12-21 2008-05-15 Resuscitation Technologies, LLC, Santa Monica STABLE T3 COMPOSITIONS AND ITS APPLICATION
CN1325651C (en) * 2001-05-24 2007-07-11 大连金威基因技术有限公司 High-efficiency expression and application of human recombinant interferon B
CN1535724B (en) * 2003-04-23 2012-09-05 北京金迪克生物技术研究所 New application of recombinant human interferon for preventing serious acute respiratory tract syndrome
CA2707484C (en) * 2007-12-04 2021-08-10 Remedy Pharmaceuticals, Inc. Improved formulations and methods for lyophilization and lyophilates provided thereby
WO2022056233A1 (en) * 2020-09-12 2022-03-17 Academia Sinica Re-folded human serum albumin and use thereof for anti-tumor

Also Published As

Publication number Publication date
BR9815966A (en) 2001-02-28
WO1999062542A1 (en) 1999-12-09
CN1299285A (en) 2001-06-13
NO20006022D0 (en) 2000-11-28
IS5732A (en) 2000-11-24
EA200001252A1 (en) 2001-06-25
JP2002516874A (en) 2002-06-11
IL139933A0 (en) 2002-02-10
SK17762000A3 (en) 2001-07-10
CA2333063A1 (en) 1999-12-09
EP1082132A1 (en) 2001-03-14
HUP0102241A2 (en) 2001-10-28
NO20006022L (en) 2001-01-26
EE200000694A (en) 2002-06-17
AU8822598A (en) 1999-12-20
KR20010052454A (en) 2001-06-25

Similar Documents

Publication Publication Date Title
TR199903331T2 (en) Farnesil protein transferase inhibitors.
TR200001218T2 (en) Substituted carboxamidothiazoles, their manufacture and pharmaceutical compositions containing them.
DK0960127T3 (en) Isolated dimeric fibroblast activating protein alpha and uses thereof
PE20000560A1 (en) USE OF PEG-IFN-ALPHA AND RIBAVIRIN FOR THE TREATMENT OF CHRONIC HEPATITIS C
ATE327254T1 (en) INTERFERON-BETA FUSION PROTEINS AND THEIR USES
JO2034B1 (en) LH-RH peptide analogues, their uses and pharmaceutical compositions containing them
ATE383169T1 (en) COMPONENT AND COMPOSITIONS FOR ADMINISTRATION OF ACTIVE INGREDIENTS
DE3684220D1 (en) COMPOSITION WITH DELAYED DELIVERY.
ATE231872T1 (en) THIAZOLOPYRIMIDE DERIVATIVES
TW200510528A (en) Polypeptide inducing apoptosis
EA200501699A1 (en) STABILIZED INTERFERON LIQUID COMPOSITIONS, NOT CONTAINING HUMAN SERUM ALBUMIN
BR9811094A (en) Therapeutic agent for lymphatic tumors
IT1293778B1 (en) 1,4,7,10-TETRAAZABICICLO (8.2.2.)TETRADECAN-2 ONE, ITS PREPARATION AND USE FOR THE PREPARATION OF TETRAAZAMACROCYCLES
TR199902334T2 (en) New therapeutic combinations of mirtazapine and antipsychotic agents for the treatment or prophylaxis of psychotic disorders.
ES2117976T3 (en) PREPARATION OF N-ACETYL NEURAMINIC DERIVATIVES.
SE9702680D0 (en) New formulation
DE59010205D1 (en) Hirudin muteins and their polyalkylene glycol conjugates
TR200003521T2 (en) Re-combined human interferon beta-1a (IFN-beta-1a) formulation.
TR200101493T2 (en) Eletriptan hydrobromide monohydrate
DK0773782T3 (en) Terpene derivatives (sarcodictyins) use as antitumor agents
EA200000875A1 (en) PROTEINS INTERACTING WITH CASPASE-8
TR199901380A2 (en) Di-ya da triazo-spiro$4.5] dean t�revleri
BR9714376A (en) Somatostatin antagonists
ES2142840T3 (en) PROTEIN THAT JOINS THE ALPHA / BETA INTERFERON, ITS PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT.
ITRM920603A0 (en) THE SEQUENCE OF THE CPRL3 INSERT, PART OF THE CRYPTOSPORIDIUM OOCIST PROTEIN (COWP) GENE, AND USEFUL DERIVATIVES FOR THE DIAGNOSIS OF CRYPTOSPORIDIUM INFECTION